Frazier Financial Advisors »

Rigel Pharmaceuticals shares owned by Frazier Financial Advisors

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Frazier Financial Advisors from 13F filings

Historical chart of Frazier Financial Advisors investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Frazier Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Frazier Financial Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $487 18 27.06

More positions owned by Frazier Financial Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Capital Group Gbl Growth Eqt Shs Creation Uni (CGGO)
Vanguard Index Fds Total Stk Mkt (VTI)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Goldman Sachs Etf Tr Ultra Short Bond (GSST)
Wisdomtree Tr Dynamic Intl Eqt (DDWM)
Wisdomtree Tr Us Midcap Divid (DON)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Specialized Funds Div App Etf (VIG)
Wisdomtree Tr Us Smallcap Divd (DES)
Abbvie (ABBV)
Apple (AAPL)
Abbott Laboratories (ABT)
Accenture Plc Ireland Shs Class A (ACN)
JPMorgan Chase & Co. (JPM)

View all positions for Frazier Financial Advisors

Top funds holding Rigel Pharmaceuticals

BlackRock
Armistice Capital
State Street Corporation
Vanguard Group
Vanguard Capital Management
Acadian Asset Management
Marshall Wace
LSV Asset Management
Renaissance Technologies
D. E. Shaw & Co
Geode Capital Management
Goldman Sachs Group
Arrowstreet Capital, Limited Partnership
Two Sigma Investments
Dimensional Fund Advisors

View all funds holding Rigel Pharmaceuticals